Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Acura Pharmaceuticals, Inc.    ACUR   US00509L7038

News SummaryMost relevantAll newsSector news 

Acura Pharmaceuticals, Inc. : Analysis Reports On Active Stocks: (NASDAQ: ACUR), (NYSE: SMFG)

04/25/2013 | 02:40pm US/Eastern

New York (April 25th, 2013) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR) traded in the range of $2.56 and $2.74 during its latest trading session. The stock recorded the volume of 329,570 shares. Currently, it is at $2.68, up 3.67 from its previous close. Its average daily trading volume stands at 763,216 shares. Its MACD chart shows bullish trend. The company?s current market capitalization stands at $123.15 million.

Acura Pharmaceuticals stock has traded in the range of $1.06 and $4.50 in the past 52 weeks and has lost 17.13 percent of its value in the same time period. The stock has low volatility as its beta stands at 0.86.

Find out what could be next for ACUR here:

Sumitomo Mitsui Financial Group Inc. (NYSE: SMFG) stock is at $9.41, up 3.63 percent from its previous close of $9.08. The stock shows bullish trend as it made the up move with trading volume of 4.484 million shares, in contrast to the average daily trading volume of 2.044 million shares. Its bullish trend is further confirmed by its MACD chart and the stock is also trading in line with its 20 days SMA of $9.41.

Sumitomo Mitsui Financial stock is mildly volatile with its beta at 1.03. The company?s market capitalization is at $63.70 billion.

Find out more on SMFG here:

About Us: issues momentum alerts on stocks that can provide gains to day traders and short-term investors. provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains. monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:

Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit:

Contact Info:
Thomas Greene
Wall Street Scoop

© Accesswire 2013
React to this article
03/26 ACURA PHARMACEUTICALS : Updates on Successful Topline Results From Nexafed Exten..
03/23 ACURA PHARMACEUTICALS : Reports Successful Topline Results From Nexafed(R) Exten..
03/19 ACURA PHARMACEUTICALS : Notice of Delisting or Failure to Satisfy a Continued Li..
03/08 ACURA PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2014 Financial Re..
03/02 ACURA PHARMACEUTICALS : to Host 2014 Financial Results Conference Call on March ..
03/02 ACURA PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2014 Financial Re..
02/23 ACURA PHARMACEUTICALS : to Host 2014 Financial Results Conference Call on March ..
02/16 ACURA PHARMACEUTICALS : Initiates Clinical Study of Meth-Resistant Nexafed(R) Ex..
02/05 ACURA PHARMACEUTICALS : Expands Meth-Resistant Decongestant Line With NEXAFED(R)..
01/08 ACURA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Creation of ..
Duration : Period :
Acura Pharmaceuticals, Inc Technical Analysis Chart | ACUR | US00509L7038 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes